Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells

Abstract
No abstract available
Funding Information
  • National Institutes of Health (DK 56930)
  • National Cancer Institute (P50CA90388)

This publication has 54 references indexed in Scilit: